KaydedilenlerDerginizi ekleyin

Dergiler / The European Research Journal / 2026 / Volume: 4 Issue: 3

Refractory status epilepticus responding to lidocaine: a case report

Gökhan Özer(Department of Neurology, Sanko Universty School of Medicine, Gaziantep)0000-0003-0039-2350
Sayfa
—
Yayın Tarihi
2018-07-04
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Here, we discuss a patient with refractory status epilepticus who achieved a very good response and full recovery only with lidocain infusion among all forms of therapy given.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Status epilepticus is a life-threatening condition, which is associated with a high mortality and morbidity when left untreated.
📊
Temel Bulgular & Veri:It is defined as a continuous seizure lasting more than 30 min or successive seizures with no recovery between any of them .
💡
Sonuç & Katkı:Here, we discuss a patient with refractory status epilepticus who achieved a very good response and full recovery only with lidocain infusion among all forms of therapy given.
🔬Tür:Case Report
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:status epilepticus · lidocaine · antiepileptic drugs

Abstract

Status epilepticus is a life-threatening condition, which is associated with a high mortality and morbidity when left untreated. It is defined as a continuous seizure lasting more than 30 min or successive seizures with no recovery between any of them . Mortality of status epilepticus depends on the duration and type of seizure, concomitant diseases and age of the patient. Managament of status epilepticus includes ensuring adequate airway, stabilization of circulation and use of antiepileptic drugs. Benzodiazepines, phenobarbital, phenytoin, fosphenytoin, general anesthesia and lidocaine are used for the treatment of status epilepticus. Here, we discuss a patient with refractory status epilepticus who achieved a very good response and full recovery only with lidocain infusion among all forms of therapy given.

🔖

Bu Makaleye Atıf Yap

Özer, G. (2018). Refractory status epilepticus responding to lidocaine: a case report. The European Research Journal, Volume: 4 Issue: 3. https://doi.org/10.18621/eurj.361883

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (9)

  1. Canas N, Delgado H, Silva V, Pinto AR, Sousa S, Simões R, et al. The electroclinical spectrum, etiologies, treatment and outcome of nonconvulsive status epilepticus in the elderly. Epilepsy Behav 2017;79:53-7.
  2. Brophy GM, Bell R, Claassen J, Alldredge B, Bleck TP, Glauser T, et al. Guidelines for the evaluation and management of status epilepticus. Neurocrit Care 2012;17:3-23.
  3. Towne AR, Pellock JM, Ko D, DeLorenzo RJ. Determinants of mortality in status epilepticus. Epilepsia 1994;35:27-34.
  4. DeLorenzo RJ, Ko D, Towne AR, Garnett LK, Boggs JG, Waterhouse EJ, et al. Prediction of outcome in status epilepticus. Epilepsia 1997;38(suppl 8):210-5.
  5. Riviello JJ Jr, Claassen J, LaRoche SM, Sperling MR, Alldredge B, Bleck TP, et al. Treatment of status epilepticus: an international survey of experts. Neurocrit Care 2013;18:193-200.
  6. Lempl Y, Eshel Y, Gilad R, Sarova-Pinchas I. Chloral hydrate in intractable status epilepticus. Ann Emerg Med 1990;19:674-6.
  7. Knake S, Gruener J, Hattemer K, Klein KM, Bauer S, Oertel WH, et al Intravenous levetiracetam in the treatment of benzodiazepine-refractory status epilepticus. J Neurol Neurosurg Psychiatry 2008;79:588-9.
  8. Agarwal P, Kumar N, Chandra R, Gupta G, Antony AR, Garg N. Randomized study of intravenous valproate and phenytoin in status epilepticus. Seizure 2007;16:527-32.
  9. Mori K, Ito H, Toda Y, Hashimoto T, Miyazaki M, Saijo T, et al. Successful management of intractable epilepsy with lidocaine tapes and continuous subcutaneous lidocaine infusion. Epilepsia 2004;45:1287-90.